200 related articles for article (PubMed ID: 35372377)
1. Comprehensive Analysis of SMC Gene Family Prognostic Value and Immune Infiltration in Patients With Pancreatic Adenocarcinoma.
Nie H; Wu Y; Ou C; He X
Front Med (Lausanne); 2022; 9():832312. PubMed ID: 35372377
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
Front Genet; 2022; 13():848391. PubMed ID: 35601487
[No Abstract] [Full Text] [Related]
3.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic Analysis of Prognostic Value of Pyroptosis-Related Genes and Its Effect on Immune Cell Infiltration in Pancreatic Adenocarcinoma.
Wang J; Zhang H; Shao P; Zhang X; Zhou B
Int J Gen Med; 2022; 15():2311-2319. PubMed ID: 35256857
[TBL] [Abstract][Full Text] [Related]
5. The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
Yu X; Sun R; Yang X; He X; Guo H; Ou C
J Cancer; 2023; 14(12):2274-2288. PubMed ID: 37576396
[TBL] [Abstract][Full Text] [Related]
6. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma.
Li Y; Su Z; Wei B; Liang Z
Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
8. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration.
Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y
Front Genet; 2022; 13():1022626. PubMed ID: 36685833
[No Abstract] [Full Text] [Related]
9. Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Front Mol Biosci; 2022; 9():1096679. PubMed ID: 36589239
[No Abstract] [Full Text] [Related]
10. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
11. Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Aging (Albany NY); 2023 Jun; 15(12):5569-5591. PubMed ID: 37354211
[TBL] [Abstract][Full Text] [Related]
12. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach.
Liu S; Liu P; Fei X; Zhu C; Hou J; Wang X; Pan Y
Oncol Lett; 2023 Jul; 26(1):285. PubMed ID: 37274465
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma.
Ren Y; Chen B; Zhang M; Xu F
Medicine (Baltimore); 2023 Feb; 102(8):e32976. PubMed ID: 36827067
[TBL] [Abstract][Full Text] [Related]
14. LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma.
Xu R; Hu Y; Xie Q; Zhang C; Zhao Y; Zhang H; Shi H; Wang X; Shi C
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428619
[TBL] [Abstract][Full Text] [Related]
15. CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.
Huang H; Zhou W; Chen R; Xiang B; Zhou S; Lan L
Front Mol Biosci; 2021; 8():611508. PubMed ID: 33681290
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142223
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of expression profiles and prognostic significance of the FGF gene family in pancreatic adenocarcinoma.
Chen YX; Liu XJ; Yang L; He JJ; Jiang YM; Mai J
Oncol Lett; 2022 Dec; 24(6):435. PubMed ID: 36311692
[TBL] [Abstract][Full Text] [Related]
19. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
20. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]